This study demonstrates that silencing USP11 blocks the release of pro-inflammatory cytokines following intracerebral hemorrhage by inhibiting the activation of the NF-κB pathway through the P53/KLF2 axis, thus protecting against neurological impairment. Here, TP53 is linked to intracerebral hemorrhage.